Endometrial Cancer Department of Clinical Effectiveness V10 Approved by the Executive Committee of the Medical Staff on 06/26/2018 INITIAL EVALUATION Hysterectomy3, BSO, and SLN mapping (ACOG) Guidelines for referral ACOG; Skip Navigation Links. Patient Education: Your Pregnancy and Childbirth (2) Pamphlets (152) Its main symptom is abnormal uterine bleeding. Endometrial cancer often is found early in the course of the disease, when it is most treatable. Endometrial cancer — Learn about the signs and symptoms, diagnosis, and treatment of this uterine cancer that occurs most often in women after menopause. Committee on Practice Bulletins — Obstetrics. ACOG Practice Bulletin No. 149: Endometrial cancer. Obstetrics & Gynecology. 2015;125 Changes in uterine cancer staging were made from the American Joint Committee on Cancer (AJCC) 6th to 7th edition staging manuals, and 8 site-specific factors (SSFs) and 3 histologic schemas were endometrial cancer.3 Endometrial hyperplasia represents a pre- on consensus guidelines Women with abnormal uterine bleeding should be evaluated for A recent ACOG commit- To estimate the risk for nodal metastasis in women with endometrial cancer based on uterine characteristics on pathology. (ACOG) guidelines defer to individual practice patterns. 7. Recent evidence suggests that staging of patients with endometrial cancer may have a prognostic role, Endometrial Hyperplasia, Management of (Green-top Guideline No. 67) This guideline provides clinicians with up-to-date evidence-based information regarding the management of endometrial hyperplasia. This is the first edition of this guideline. It also is used as a chemoprophylactic agent for women at high risk for breast cancer. ACOG reaffirmed their guidance on Uterine Cancer Risk (NSABBP) Within first 5 years of follow up. Average annual hazard rate of endometrial cancer: 1.2/1000 patient-years - Professional guideline New ACOG Guidance on Tamoxifen and Uterine Cancer. An